AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
The molecular basis of lung carcinogenesis
Authors: Fong, KM Sekido, Y Minna, JD
Citation: Km. Fong et al., The molecular basis of lung carcinogenesis, MOLECULAR BASIS OF HUMAN CANCER, 2002, pp. 379-405
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
Authors: Burbee, DG Forgacs, E Zochbauer-Muller, S Shivakumar, L Fong, K Gao, BN Randle, D Kondo, M Virmani, A Bader, S Sekido, Y Latif, F Milchgrub, S Toyooka, S Gazdar, AF Lerman, MI Zabarovsky, E White, M Minna, JD
Citation: Dg. Burbee et al., Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression, J NAT CANC, 93(9), 2001, pp. 691-699
Re: Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas - Response
Authors: Gazdar, AF Zochbauer-Muller, S Virmani, A Kurie, J Minna, JD Lam, S
Citation: Af. Gazdar et al., Re: Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas - Response, J NAT CANC, 93(1), 2001, pp. 67-68
Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector
Authors: Ramesh, R Saeki, T Templeton, NS Ji, L Stephens, LC Ito, I Wilson, DR Wu, Z Branch, CD Minna, JD Roth, JA
Citation: R. Ramesh et al., Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector, MOL THER, 3(3), 2001, pp. 337-350
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter1A in breast and lung carcinomas
Authors: Virmani, AK Rathi, A Sathyanarayana, UG Padar, A Huang, CX Cunnigham, HT Farinas, AJ Milchgrub, S Euhus, DM Gilcrease, M Herman, J Minna, JD Gazdar, AF
Citation: Ak. Virmani et al., Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter1A in breast and lung carcinomas, CLIN CANC R, 7(7), 2001, pp. 1998-2004
Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers
Authors: Forgacs, E Wren, JD Kamibayashi, C Kondo, M Xu, XL Markowitz, S Tomlinson, GE Muller, CY Gazdar, AF Garner, HR Minna, JD
Citation: E. Forgacs et al., Searching for microsatellite mutations in coding regions in lung, breast, ovarian and colorectal cancers, ONCOGENE, 20(8), 2001, pp. 1005-1009
Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells
Authors: Kondo, M Ji, L Kamibayashi, C Tomizawa, Y Randle, D Sekido, Y Yokota, J Kashuba, V Zabarovsky, E Kuzmin, I Lerman, M Roth, J Minna, JD
Citation: M. Kondo et al., Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells, ONCOGENE, 20(43), 2001, pp. 6258-6262
Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion
Authors: Shigemitsu, K Sekido, Y Usami, N Mori, S Sato, M Horio, Y Hasegawa, Y Bader, SA Gazdar, AF Minna, JD Hida, T Yoshioka, H Imaizumi, M Ueda, Y Takahashi, M Shimokata, K
Citation: K. Shigemitsu et al., Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion, ONCOGENE, 20(31), 2001, pp. 4249-4257
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung,breast and ovarian tumours
Authors: Agathanggelou, A Honorio, S Macartney, DP Martinez, A Dallol, A Radar, J Fullwood, P Chauhan, A Walker, R Shaw, JA Hosoe, S Lerman, MI Minna, JD Maher, ER Latif, F
Citation: A. Agathanggelou et al., Methylation associated inactivation of RASSF1A from region 3p21.3 in lung,breast and ovarian tumours, ONCOGENE, 20(12), 2001, pp. 1509-1518
PANORAMA: An integrated web-based sequence analysis tool and its role in gene discovery (vol 70, pg 300, 2000)
Authors: Pertsemlidis, A Miller, B Pande, A Mittelman, D Schilling, P Wei, MH Lerman, MI Minna, JD Garner, HR
Citation: A. Pertsemlidis et al., PANORAMA: An integrated web-based sequence analysis tool and its role in gene discovery (vol 70, pg 300, 2000), GENOMICS, 77(3), 2001, pp. 208-208
Molecular genetics of small cell lung carcinoma
Authors: Wistuba, II Gazdar, AF Minna, JD
Citation: Ii. Wistuba et al., Molecular genetics of small cell lung carcinoma, SEMIN ONCOL, 28(2), 2001, pp. 3-13
Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
Authors: Tomizawa, Y Sekido, Y Kondo, M Gao, BN Yokota, J Roche, J Drabkin, H Lerman, MI Gazdar, AF Minna, JD
Citation: Y. Tomizawa et al., Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B, P NAS US, 98(24), 2001, pp. 13954-13959
Targeted therapies for killing tumor cells
Authors: Gazdar, AF Minna, JD
Citation: Af. Gazdar et Jd. Minna, Targeted therapies for killing tumor cells, P NAS US, 98(18), 2001, pp. 10028-10030
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3is involved in kidney tumorigenesis
Authors: Dreijerink, K Braga, E Kuzmin, I Geil, L Duh, FM Angeloni, D Zbar, B Lerman, MI Stanbridge, EJ Minna, JD Protopopov, A Li, JF Kashuba, V Klein, G Zabarovsky, ER
Citation: K. Dreijerink et al., The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3is involved in kidney tumorigenesis, P NAS US, 98(13), 2001, pp. 7504-7509
Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer
Authors: Lokeshwar, VB Rubinowicz, D Schroeder, GL Forgacs, E Minna, JD Block, NL Nadji, M Lokeshwar, BL
Citation: Vb. Lokeshwar et al., Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer, J BIOL CHEM, 276(15), 2001, pp. 11922-11932
5 ' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
Authors: Zochbauer-Muller, S Fong, KM Maitra, A Lam, S Geradts, J Ashfaq, R Virmani, AK Milchgrub, S Gazdar, AF Minna, JD
Citation: S. Zochbauer-muller et al., 5 ' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer, CANCER RES, 61(9), 2001, pp. 3581-3585
gamma-radiation-induced G(2) delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer
Authors: Zhao, H Spitz, MR Tomlinson, GE Zhang, HF Minna, JD Wu, XF
Citation: H. Zhao et al., gamma-radiation-induced G(2) delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer, CANCER RES, 61(21), 2001, pp. 7819-7824
Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers
Authors: Xu, XL Wu, LC Du, FH Davis, A Peyton, M Tomizawa, Y Maitra, A Tomlinson, G Gazdar, AF Weissman, BE Bowcock, AM Baer, R Minna, JD
Citation: Xl. Xu et al., Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers, CANCER RES, 61(21), 2001, pp. 7943-7949
Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma
Authors: Toyooka, S Pass, HI Shivapurkar, N Fukuyama, Y Maruyama, R Toyooka, KO Gilcrease, M Farinas, A Minna, JD Gazdar, AF
Citation: S. Toyooka et al., Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma, CANCER RES, 61(15), 2001, pp. 5727-5730
Loss of expression and aberrant methylation of the CDH13 (H-cadherin) genein breast and lung carcinomas
Authors: Toyooka, KO Toyooka, S Virmani, AK Sathyanarayana, UG Euhus, DM Gilcrease, M Minna, JD Gazdar, AF
Citation: Ko. Toyooka et al., Loss of expression and aberrant methylation of the CDH13 (H-cadherin) genein breast and lung carcinomas, CANCER RES, 61(11), 2001, pp. 4556-4560
Aberrant promoter methylation of multiple genes in non-small cell lung cancers
Authors: Zochbauer-Muller, S Fong, KM Virmani, AK Geradts, J Gazdar, AF Minna, JD
Citation: S. Zochbauer-muller et al., Aberrant promoter methylation of multiple genes in non-small cell lung cancers, CANCER RES, 61(1), 2001, pp. 249-255
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss
Authors: Maitra, A Wistuba, II Washington, C Virmani, AK Ashfaq, R Milchgrub, S Gazdar, AF Minna, JD
Citation: A. Maitra et al., High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss, AM J PATH, 159(1), 2001, pp. 119-130
Promoter methylation and silencing of the retinoic acid receptor-beta genein lung carcinomas
Authors: Virmani, AK Rathi, A Zochbauer-Muller, S Sacchi, N Fukuyama, Y Bryant, D Maitra, A Heda, S Fong, KM Thunnissen, F Minna, JD Gazdar, AF
Citation: Ak. Virmani et al., Promoter methylation and silencing of the retinoic acid receptor-beta genein lung carcinomas, J NAT CANC, 92(16), 2000, pp. 1303-1307
Chromosome 19 translocation, overexpression of Notch3, and human lung cancer
Authors: Dang, TP Gazdar, AF Virmani, AK Sepetavec, T Hande, KR Minna, JD Roberts, JR Carbone, DP
Citation: Tp. Dang et al., Chromosome 19 translocation, overexpression of Notch3, and human lung cancer, J NAT CANC, 92(16), 2000, pp. 1355-1357
Molecular changes in the bronchial epithelium of patients with small cell lung cancer
Authors: Wistuba, II Berry, J Behrens, C Maitra, A Shivapurkar, N Milchgrub, S Mackay, B Minna, JD Gazdar, AF
Citation: Ii. Wistuba et al., Molecular changes in the bronchial epithelium of patients with small cell lung cancer, CLIN CANC R, 6(7), 2000, pp. 2604-2610
Risultati: 1-25 | 26-50 | 51-55